Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)DMB-I in the Treatment of Alzheimer Type Dementia
Phase 2
Completed
- Conditions
- Dementia of Alzheimer TypeAlzheimer Disease
- Interventions
- Drug: DMB-I (Dimebon)Other: Placebo
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Bigespas LTD
- Target Recruit Count
- 133
- Registration Number
- NCT06292351
- Locations
- 🇷🇺
State autonomous healthcare institution "Transregional Clinical Diagnostic Center", Kazan, Russian Federation
🇷🇺Federal State Budgetary Institution "Federal center for brain and neurotechnologies" of the Federal Medical and Biological Agency (FSBI "FCBN" of Russia's FMBA), Moscow, Russian Federation
🇷🇺Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation
News
No news found